Diabetic Retinopathy AI Scanner — A Screening Aid

Diabetic retinopathy is damage to the blood vessels of the retina caused by high blood glucose over time, and it is a leading cause of preventable sight loss in adults. The encouraging news is that regular eye screening catches it early, when treatment works best. JourneyForHealth offers an AI retinopathy screening aid to help raise awareness — it is a screening aid, not a diagnosis, and it does not replace an eye specialist.

What diabetic retinopathy is

Persistently high glucose can weaken and damage the tiny blood vessels in the retina, the light-sensitive layer at the back of the eye. Early on there are often no symptoms at all, which is what makes it dangerous — vision can be affected before you notice anything. Over time vessels can leak, swell or close off, and in advanced stages abnormal new vessels grow, which can lead to serious vision loss if untreated. Related complications include diabetic macular oedema. The key point: early stages are usually silent, so waiting for symptoms is not a safe strategy.

Why annual eye screening matters

Guidelines such as the ADA Standards of Care recommend regular dilated eye examinations for people with diabetes, typically starting at or soon after diagnosis for type 2 diabetes and repeating at intervals your eye specialist advises. Screening matters because:

• Early retinopathy is treatable and progression can often be slowed or halted.
• Good glucose, blood pressure and cholesterol control reduces risk.
• Most vision loss from diabetes is preventable with timely detection and care.

AI in retinopathy screening

Automated analysis of retinal photographs is one of the more established areas of medical AI. In general terms, FDA-cleared autonomous retinopathy screening systems exist and are used in some care settings to help identify people who should be referred to an eye specialist. This shows the field is real and maturing. However, that broader context does not transfer clearance or diagnostic authority to our tool.

How our scanner fits in — and what it is not

Our AI retinopathy feature is an educational screening aid designed to encourage timely eye care, not to diagnose. This is a screening aid, not a diagnosis — confirm findings with a clinician. We do not claim FDA clearance for our tool, and we do not publish a validation cohort or accuracy figure for it. A result from our scanner — reassuring or concerning — cannot replace a dilated eye examination by an optometrist or ophthalmologist. If our tool flags anything, or if you are due for screening, see an eye specialist.

Protecting your eyes

1. Keep up with regular dilated eye examinations as your specialist advises.
2. Work on glucose control — time in range and A1c both matter for your eyes.
3. Manage blood pressure and cholesterol, which also affect retinal vessels.
4. Report any sudden change in vision, floaters or dark spots promptly.

Frequently Asked Questions

Can this scanner diagnose retinopathy?

No. It is an educational screening aid meant to encourage professional eye care. Diagnosis requires an examination by an eye specialist.

How often should I have my eyes checked?

Follow your eye specialist's advice; guidelines generally recommend regular dilated exams for people with diabetes, starting at or near diagnosis for type 2 diabetes.

Is your AI tool FDA-cleared?

No. While FDA-cleared retinopathy screening systems exist in the field generally, we make no clearance claim for our tool. It is a screening aid, not a diagnostic device.

I have no vision problems — do I still need screening?

Yes. Early retinopathy usually causes no symptoms, so screening is essential even when your vision seems fine.